EACS2023: 369 HIV-positive patients with chronic total occlusion (CTO) face the dilemma of percutaneous coronary interventions H. Natraj Setty , L Sridhar , K. Jayashree , T. Babu Reddy , M. Yeriswamy , P. Rahul , K. Ravindranath , D Vijay Kumar , R. Naresh , J. Santhosh , B. Srinivas , C. Manjunath Sri Jayadeva Institute of Cardiovascular Sciences and Research, Cardiology, Bangalore, India General data Abstract category: Access and delivery of care Abstract body Purpose: Chronic total occlusions of the coronary arteries (CTOs) often occur in patients with coronary artery disease. Angina and left ventricular function can both be greatly improved by a successful CTO percutaneous coronary intervention (PCI). HIV patients are at a heightened risk of adverse cardiovascular events because of the complex relationships between HIV infection itself and recognized risk factors, such as chronic endothelial dysfunction, immunological activation/inflammation, and a higher risk of thrombosis. Our study's goal was to evaluate the procedural outcomes and complications of performing PCI in patients with coronary chronic total occlusions (CTOs) who also tested positive for retroviruses. Method: 13 patients who were reported as having retroviral positive with CTO between august-2013 and august-2022 were evaluated. Detailed clinical presentation and coronary angiography of all patients were evaluated. Results: A 100% procedural success rate was achieved and the in-hospital course was uneventful. 9 patients had 100 % LAD occlusion, 3 patients were 100% RCA occlusion, and 1 patient had 100% LMCA and LAD Occlusion. Out of 13 patients, 9 patients had PCI to LAD, 3 patients had PCI to RCA, and 1 patient had PCI to LMCA to LAD. The average size of the stent was 3x30mm. 1st Death due to non-compliance with medication and 2nd death due to AWMI and cardiogenic shock. During the follow-up period of 5 years, there were no reported major adverse cardiovascular events, and the patients were found to have definite symptom benefits from this procedure. Conclusions: PCI is an adequate and safe treatment strategy for coronary revascularization in HIV POSITIVE patients with coronary chronic total occlusion; post PCI, there is the definite symptomatic and prognostic benefit of PCI in HIV-positive patients with coronary CTO. General conditions 1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after the submission deadline and I am aware that it will be published exactly as submitted.: Yes 2. I confirm that the submission of the abstract constitutes my consent to publication (e.g. conference website, programmes, other promotions, etc.). : Yes 3. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.: Yes 4. I agree that all data provided may be used (saved, stored, processed, transmitted and deleted) in compliance with the privacy policy to provide the services described.: Yes 1 1 1 1 1 1 1 1 1 1 1 1 1 19
RkJQdWJsaXNoZXIy Mzc2ODc=